Proteomics for the development of vaccines and therapeutics

Critical Reviews in Immunology

Volumn 30, Issue 3, 2010, Pages 239-254

  Delvecchio, Vito G ^a   Sabato, Mark A ^a   Trichilo, Jessica ^a   Dake, Clarissa ^a   Grewal, Paul ^a   Alefantis, Tim ^a  

^a Vital Probes Inc   (United States)

Author keywords

Antigen identification; B cell epitopes; Bacillus anthracis; Immunoproteomics; LC MS MS; MALDI TOF; Moonlighting proteins; Proteomics; Therapeutics; Vaccines

Indexed keywords

ADJUVANT; ANTHRAX VACCINE; ANTIGEN; BACTERIAL PROTEIN; CHAPERONE; EPITOPE; IMMUNOMODULATING AGENT; BACTERIAL VACCINE; IMMUNOLOGICAL ADJUVANT;

B LYMPHOCYTE; BACILLUS ANTHRACIS; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG TARGETING; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEOMICS; REVIEW; ANIMAL; CHEMISTRY; DRUG DEVELOPMENT; IMMUNOLOGY; PROCEDURES;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL VACCINES; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 77950975441     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v30.i3.20     Document Type: Review

References (35)

1. Brahmbhatt TN Darnell SC Carvalho HM Sanz P Kang TJ Bull RL Rasmussen SB Cross AS O'Brien AD. Recombinant exosporium protein BclA of Bacillus anthracis is efective as a booster for mice primed with suboptimal amounts of protective antigen. Infect Immun. 2007, Nov 75. 11, 5240-5247
2. Brossier F, Levy M, Mock M. Anthrax spores make an essential contribution to vaccine efcacy. Infect Immun. 2002 Feb;70(2):661-664
3. Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR. Efcacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Infect Immun. 2009 Mar;77(3):1197-1207
4. Shlyakhov EN, Rubinstein E. Human live anthrax vaccine in the former USSR. Vaccine. 1994;12(8):727-730 (Pubitemid 24182373)
5. Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shaferman A. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun. 2000 Aug;68(8):4549-4558
6. DelVecchio VG, Connolly JP, Alefantis TG, Walz A, Quan MA, Patra G, Ashton JM, Whittington J T, Chafn RD, Liang X, Grewal P, Khan AS, Mujer CV. Proteomic profling and identifcation of immu-nodominant spore antigens of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Appl Environ Microbiol. 2006 Sep;72(9):6355-6363
7. Lamonica JM, Wagner M, Eschenbrenner M, Williams LE, Miller TL, Patra G, DelVecchio VG. Comparative secretome analyses of three Bacillus anthracis strains with variant plasmid contents. Infect Immun. 2005 Jun;73(6):3646-3658
8. Severin A, Nickbarg E, Wooters J, Quazi SA, Matsuka YV, Murphy E, Moutsatsos IK, Zagursky RJ, Olmsted SB. Proteomic analysis and identifcation of Streptococcus pyogenes surface-associated proteins. J Bacteriol. 2007 Mar;189(5):1514-1522
9. Walz A, Mujer CV, Connolly JP, Alefantis T, Chafn R, Dake C, Whittington J, Kumar SP, Khan AS, DelVecchio VG. Bacillus anthracis secretome time course under host-simulated conditions and iden-tifcation of immunogenic proteins. Proteome Sci. 2007;5:11.
10. Harper M, Lema F, Boulot G, Poljak RJ. Antigen speci-fcity and cross-reactivity of monoclonal anti-lysozyme antibodies. Mol Immunol. 1987 Feb;24(2):97-108.
11. Jemmerson R, Paterson Y. Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes. Science. 1986 May 23;232(4753): 1001-1004
12. Kiselar JG, Downard KM. Direct identification of protein epitopes by mass spectrometry without immobilization of antibody and isolation of antibody-peptide complexes. Anal Chem. 1999 May 1;71(9):1792-1801
13. Kiselar JG, Downard KM. Preservation and detection of specifc antibody-peptide complexes by matrix-assisted laser desorption ionization mass spectrometry. J Am Soc Mass Spectrom. 2000 Aug;11(8):746-750
14. Jefery CJ. Mass spectrometry and the search for moonlighting proteins. Mass Spectrom Rev. 2005 Nov;24(6):772-782
15. Agarwal S, Kulshreshtha P, Bambah MD, Bhatnagar R. alpha-Enolase binds to human plasminogen on the surface of Bacillus anthracis. Biochim Biophys Acta. 2008 Jul;1784(7-8):986-994
16. Henderson B, Allan E, Coates AR. Stress wars: the direct role of host and bacterial molecular chap-erones in bacterial infection. Infect Immun. 2006 Jul;74(7):3693-3706
17. Lahteenmaki K, Edelman S, Korhonen TK. Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 2005 Feb;13(2):79-85.
18. Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafn R, Grewal P, Mujer CV, Ugalde RA
19. DelVecchio VG. Proteomic analysis of Brucella abortus cell envelope and identifcation of immunogenic candidate proteins for vaccine development. Proteomics. 2006 Jul;6(13):3767-3780
20. Egea L, Aguilera L, Gimenez R, Sorolla MA, Aguilar J, Badia J, Baldoma L. Role of secreted glyceraldehyde-3-phosphate dehydrogenase in the infection mechanism of enterohemorrhagic and enteropathogenic Escherichia coli: interaction of the extracellular enzyme with human plasminogen and fbrinogen. Int J Biochem Cell Biol. 2007;39(6):1190-1203
21. Knaust A, Weber MV, Hammerschmidt S, Bergmann S, Frosch M, Kurzai O. Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria men-ingitidis. J Bacteriol. 2007 Apr;189(8):3246-3255
22. Magalhaes V, Veiga-Malta I, Almeida MR, Baptista M, Ribeiro A, Trieu-Cuot P, Ferreira P. Interaction with human plasminogen system turns on proteolytic activity in Streptococcus agalactiae and enhances its virulence in a mouse model. Microbes Infect. 2007 Sep;9(11):1276-1284
23. Pancholi V, Chhatwal GS. Housekeeping enzymes as virulence factors for pathogens. Int J Med Microbiol. 2003 Dec;293(6):391-401.
24. Bergmann S, Wild D, Diekmann O, Frank R, Bracht D, Chhatwal GS, Hammerschmidt S. Identifcation of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol. 2003 Jul;49(2):411-423
25. La CS, Sauvageot N, Giard JC, Benachour A, Posteraro B, Aufray Y, Sanguinetti M, Hartke A. Comparative study of the physiological roles of three peroxidases (NADH peroxidase, Alkyl hydroperoxide reductase and Tiol peroxidase) in oxidative stress response, survival inside macrophages and virulence of Enterococcus faecalis. Mol Microbiol. 2007 Dec;66(5):1148-1163
26. Nurgalieva ZZ, Conner ME, Opekun AR, Zheng CQ, Elliott SN, Ernst PB, Osato M, Estes MK, Graham DY. B-cell and T-cell immune responses to experimental Helicobacter pylori infection in humans. Infect Immun. 2005 May;73(5):2999-3006.
27. Crowe JD, Sievwright IK, Auld GC, Moore NR, Gow NA, Booth NA. Candida albicans binds human plas-minogen: identifcation of eight plasminogen-binding proteins. Mol Microbiol. 2003 Mar;47(6):1637-1651
28. Candela M, Bergmann S, Vici M, Vitali B, Turroni S, Eikmanns BJ, Hammerschmidt S, Brigidi P. Binding of human plasminogen to Bifdobacterium. J Bacteriol. 2007 Aug;189(16):5929-5936
29. Pal-Bhowmick I, Mehta M, Coppens I, Sharma S, Jarori GK. Protective properties and surface localization of Plasmodium falciparum enolase. Infect Immun. 2007 Nov;75(11):5500-5508
30. Sha J, Erova TE, Alyea RA, Wang S, Olano JP, Pancholi V, Chopra AK. Surface-expressed enolase contributes to the pathogenesis of clinical isolate SSU of Aeromonas hydrophila. J Bacteriol. 2009 May;191(9):3095-3107
31. Zhang A, Chen B, Mu X, Li R, Zheng P, Zhao Y, Chen H, Jin M. Identifcation and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2. Vaccine. 2009 Feb 25;27(9): 1348-1353
32. Patti JM. A humanized monoclonal antibody targeting Staphylococcus aureus. Vaccine. 2004;22(Suppl 1): S39-43.
33. Reilley S, Wenzel E, Reynolds L, Bennett B, Patti JM, Hetherington S. Open-label, dose escalation study of the safety and pharmacokinetic profle of tefbazumab in healthy volunteers. Antimicrob Agents Chemother. 2005 Mar;49(3):959-962
34. Weems JJ, Jr., Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore T, Patti JM, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG, Jr. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefbazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006 Aug;50(8):2751-2755
35. O?Brien-Simpson NM, Pathirana RD, Paolini RA, Chen YY, Veith PD, Tam V, Ally N, Pike RN, Reynolds EC. An immune response directed to proteinase and adhesin functional epitopes protects against Porphyromonas gingivalis-induced peri-odontal bone loss. J Immunol. 2005 Sep 15;175(6): 3980-3989